Search Results for agency_names:"Justice Department"

Catalent Greenville, Inc. has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances. The company plans to use these substances for developing bulk dosage formulations for research and clinical trials. People or organizations that have an interest in this matter can submit comments or request a hearing by March 3, 2025. Submissions can be made through the Federal eRulemaking Portal, and hearings request should be sent to the DEA at specified addresses.

The Global Synchronizer Foundation (GSF) has filed notifications with the Attorney General and the Federal Trade Commission about changes in its membership. This action is in line with the National Cooperative Research and Production Act of 1993, which limits the recovery of damages for antitrust plaintiffs. New members joining the GSF include the Hong Kong Monetary Authority, Copper Markets (Switzerland) AG, Goldman Sachs & Co. LLC, and Bank of New York Mellon Corporation. The organization intends to continue updating its membership details to comply with the Act's requirements.

Sigma Aldrich Research Biochemicals Inc. has applied to the Drug Enforcement Administration to become a registered bulk manufacturer of certain controlled substances. The company intends to produce these substances for use as reference standards only, and no other uses are approved under this registration. The public can submit comments or objections electronically regarding this application until May 12, 2025, through the Federal eRulemaking Portal. Additionally, requests for a hearing on the application must also be made by this date.

The Federal Bureau of Investigation's (FBI) Criminal Justice Information Services (CJIS) Division, part of the Department of Justice (DOJ), has announced a proposal to revise a previously approved information collection, specifically the FBI Expungement and Sealing Form (FD-1114). This notice, in compliance with the Paperwork Reduction Act, invites public comments on the necessity, accuracy, and enhancement of the information collection, which is mandatory for state, local, tribal, and federal agencies. The collection aims to ensure accurate and secure identity history records in systems like the National Crime Information Center. The estimated annual response rate for this form is 147,610, with each response taking approximately 3.5 minutes, totaling an annual burden of 8,611 hours. Comments will be accepted until March 10, 2025.

The Department of Justice has lodged a proposed Consent Decree with the U.S. District Court for the Eastern District of Missouri regarding environmental claims at the Madison County Mines Superfund Site. The settlement involves Delta Asphalt, Inc., and aims to resolve contamination-related claims under federal and Missouri state environmental laws. Delta Asphalt will place controls on their property to allow the Environmental Protection Agency and the State to conduct necessary remedial actions. There is a public comment period, and individuals may submit comments and request a public meeting within 30 days of this notice.

The Customer Experience Hub (CX Hub) has informed the Attorney General and the Federal Trade Commission about changes in its membership, following the National Cooperative Research and Production Act of 1993. New members added to the CX Hub include numerous organizations across various states, such as Alethium Technologies and Baylor College of Medicine. The CX Hub aims to limit antitrust plaintiffs' recovery to actual damages under specific conditions, and it plans to continue updating the authorities regarding any further membership changes. This is part of an ongoing effort to comply with antitrust regulations and maintain transparency in cooperative research efforts.

The Department of Justice's Antitrust Division has announced that the Expeditionary Missions Consortium—Crane (EMC2) filed notifications about updates to its membership. These updates were sent to the Attorney General and the Federal Trade Commission as part of a rule under the National Cooperative Research and Production Act of 1993. This act limits the recovery of damages by antitrust plaintiffs in certain situations. The consortium added many new members, including research institutions and companies from various states. Membership in the consortium remains open, and EMC2 plans to notify authorities of future changes in its membership.

The Department of Justice has announced that the Subcutaneous Drug Development & Delivery Consortium, Inc. has updated its membership with the addition of Sanofi, a company from Paris, France. This notification was filed under the National Cooperative Research and Production Act, which allows for certain antitrust protections. The consortium's project membership remains open, and it plans to disclose further changes in the future. Previously, an initial notice was published by the Department of Justice in the Federal Register in December 2020.

The Open Source Imaging Consortium, Inc. has updated its membership by adding Qureight, Ltd. from Cambridge, United Kingdom. This update was filed on September 27, 2024, under the National Cooperative Research and Production Act of 1993, which helps limit antitrust plaintiffs' recovery to actual damages in certain situations. The Consortium intends to keep membership open and plans to report further changes. Previously, updates were published in the Federal Register on June 21, 2024, and the original notice was filed on March 20, 2019.

The Drug Enforcement Administration (DEA) has revoked Samreen Riaz, D.D.S.'s registration to handle controlled substances due to her lack of authority to practice dentistry in California, where her DEA registration was held. The decision was made following the Dental Board of California's revocation of her dental license, effective September 1, 2023. Riaz did not respond to the Order to Show Cause (OSC), resulting in her default and the revocation of her DEA registration. The DEA's action ensures that individuals without the necessary state licenses cannot handle controlled substances, maintaining compliance with federal regulations.